MarketCapExport financials
ThermoGenesis Holdings (THMO)
The export includes the complete available history of financial statements and ratios. Numbers are provided in full, without million or billion abbreviations, in their original reporting units.
CSV downloads as a ZIP archive with one file for each report and frequency.
Facebook
X
Telegram
ThermoGenesis Holdings Income Statement 2023-2009 | THMO
Brief overview of profit and loss at ThermoGenesis Holdings
This overview is based on financial performance over the past five years. ThermoGenesis Holdings reported revenue of 9.7 million dollars in 2018 and 9.4 million dollars by 2023. Across the full period, sales moved by −2.3%; the average annual rate was −0.5%. Sales changed only slightly and remained broadly flat.
Gross profit was 2.2 million dollars at the start and 1.9 million dollars at the end of the period (−11.9%). Direct costs broadly followed the top-line trend. The gross margin was 22.7% at the start and 20.4% at the end. The margin decline reflects a less favorable sales-and-cost structure.
EBITDA was −$42.9 million at the beginning and −$7.5 million at the end of the period (+82.6%). EBITDA expanded faster than the top line. EBITDA margin was −443.3% at the start and −79% at the end. Higher profitability strengthens the quality of operating growth.
Across the five years, the net result shifted from −$40.9 million to −$18.9 million. Losses became smaller, but the business remains unprofitable.
Conclusion
Signs of deterioration dominate the five-year picture. The financial profile benefits from improving net profitability and positive operating leverage. The main areas of concern are a softer top-line trend, pressure from direct costs and limited operating profitability. The next reporting periods will show whether revenue, margins, and final profitability can strengthen.
Annual Income Statement ThermoGenesis Holdings
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
- | 2.09 M | 168 K | 17.9 M | 11.3 M | 6.81 M | 287 M | 237 M | 88.8 M | 4.41 B | 7.34 B | 3.05 B | 2.99 B | - | - |
Shares |
2.37 M | 551 K | 262 K | 6.28 M | 2.83 M | 1.84 M | 10.1 M | 7.93 M | 2.02 M | 24.2 M | 16.5 M | 16.4 M | 14.8 M | 14 M | - |
Historical Prices |
- | 3.8 | 0.64 | 2.85 | 3.98 | 3.7 | 28.4 | 29.9 | 44 | 182 | 444 | 186 | 202 | - | 19.5 K |
Net Income |
-18.9 M | -11.8 M | -11.9 M | -16.8 M | -10.1 M | -40.9 M | -2.28 M | -25.8 M | -14.9 M | -8.63 M | -3.09 M | -4.99 M | -2.57 M | -486 K | - |
Revenue |
9.44 M | 10.5 M | 9.29 M | 9.74 M | 13 M | 9.67 M | 6.01 M | 11.9 M | 16 M | 16 M | 18 M | 19 M | 23.4 M | - | - |
Cost of Revenue |
7.51 M | 7.77 M | 5.8 M | 8.48 M | 7.35 M | 7.48 M | 3.86 M | 4.84 M | 11.3 M | 10.1 M | 11.6 M | 12.7 M | 14.6 M | 15.6 M | - |
Gross Profit |
1.93 M | 2.71 M | 3.49 M | 1.26 M | 5.7 M | 2.19 M | 2.16 M | 2.93 M | 4.75 M | 5.89 M | 6.36 M | 6.33 M | 8.84 M | 2.36 M | - |
Operating Income |
-8.61 M | -6.19 M | -7.23 M | -8.9 M | -4.73 M | -43.5 M | -4.6 M | -5.52 M | -14.9 M | -9.04 M | -3.06 M | -5.38 M | -2.84 M | 5.25 M | - |
Interest Expense |
10 M | 5.62 M | 6.1 M | 7.91 M | 4.48 M | 2.7 M | 541 K | 10.5 M | 14 K | - | - | - | - | - | - |
EBITDA |
-7.46 M | -5.27 M | -6.6 M | -8.15 M | -3.93 M | -42.9 M | -4.28 M | -4.35 M | -13.5 M | -8.05 M | -2.53 M | -4.78 M | -2.37 M | 5.75 M | - |
Operating Expenses |
10.5 M | 8.9 M | 10.7 M | 10.2 M | 10.4 M | 45.7 M | 6.75 M | 8.46 M | 19.6 M | 14.9 M | 9.43 M | 11.7 M | 11.7 M | 12.7 M | - |
General and Administrative Expenses |
7.22 M | 7.24 M | 8.52 M | 5.73 M | 6.38 M | 8.29 M | 3.57 M | 6.32 M | 10.7 M | 8.49 M | 5.64 M | 5.22 M | 5.47 M | - | - |
Annual performance
Select metrics to display
All numbers in USD currency
Quarterly Income Statement ThermoGenesis Holdings
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
4.03 M | 3.62 M | 2.5 M | 2.48 M | 1.25 M | 1.04 M | 31.3 M | 13.5 M | 12.3 M | 11.9 M | 11.9 M | 11.9 M | 11.4 M | 8.93 M | 6.71 M | 6.32 M | 4.14 M | 2.84 M | 2.91 M | 2.78 M | 24.6 M | 2.17 M | 22.1 M | 15.4 M | 10.9 M | 10.9 M | 9.89 M | 9.85 M | 9.95 M | 9.85 M | 2.72 M | 41.4 M | 40.6 M | 2.07 M | 40.4 M | 40.3 M | 40.3 M | 40.3 M | 28.4 M | 16.7 M | 16.7 M | 16.7 M | 16.5 M | 16.5 M | 16.5 M | 16.5 M | 16.4 M | 16.4 M | 16.4 M | 16.4 M | 16.4 M | 16.3 M | 14.8 M |
Net Income |
-2 M | - | -3.74 M | -2.4 M | -5.18 M | - | -3.4 M | -2.8 M | -2.04 M | - | -1.79 M | -4.67 M | -2.53 M | - | -2.61 M | -6.51 M | -4.74 M | - | -2.37 M | -1.48 M | -2.05 M | - | -2.76 M | -27.2 M | -3.37 M | - | -2.1 M | -3.4 M | -2.59 M | -3.4 M | -10.9 M | -624 K | -3.4 M | -624 K | -4.81 M | -4.37 M | -3.3 M | -4.37 M | -1.86 M | -1.6 M | -2.3 M | -1.6 M | -1.12 M | -563 K | 995 K | -563 K | -1.76 M | -1.28 M | -1.21 M | -1.28 M | -1.21 M | -1.28 M | -1.21 M |
Revenue |
2.74 M | - | 2.19 M | 2.27 M | 2.57 M | - | 2.12 M | 3.03 M | 2.66 M | - | 3.16 M | 2.2 M | 1.52 M | - | 2.36 M | 2.24 M | 3.2 M | - | 4.06 M | 4.3 M | 2.96 M | - | 3.11 M | 2 M | 1.87 M | - | 3.07 M | 3.5 M | 3.25 M | 4 M | 3.77 M | 7.77 M | 3.77 M | 3.29 M | 2.82 M | 3.29 M | 2.82 M | 4.64 M | 3.66 M | 4.64 M | 3.66 M | 4.47 M | 3.64 M | 4.47 M | 3.64 M | 4.8 M | 4.12 M | 4.8 M | 4.12 M | 4.78 M | 4.86 M | 4.78 M | 4.86 M |
Cost of Revenue |
1.54 M | - | 1.8 M | 1.8 M | 1.47 M | - | 1.68 M | 2.09 M | 1.72 M | - | 2.04 M | 1.22 M | 809 K | - | 844 K | 4.87 M | 1.71 M | - | 2.16 M | 2.35 M | 1.7 M | - | 2.46 M | 1.64 M | 1.52 M | - | 1.88 M | 2.45 M | 2.14 M | 2.45 M | 2.42 M | 2.27 M | 2.46 M | 2.27 M | 2.9 M | 3.1 M | 2.47 M | 3.1 M | 2.5 M | 2.68 M | 2.25 M | 2.68 M | 3.22 M | 2.83 M | 2.5 M | 2.83 M | 3.73 M | 3.07 M | 2.86 M | 3.07 M | 2.86 M | 3.07 M | 2.86 M |
Gross Profit |
1.2 M | - | 395 K | 469 K | 1.1 M | - | 437 K | 939 K | 940 K | - | 1.12 M | 986 K | 708 K | - | 1.51 M | -2.63 M | 1.49 M | - | 1.9 M | 1.95 M | 1.26 M | - | 655 K | 363 K | 352 K | - | 1.38 M | 1.55 M | 931 K | 1.55 M | 408 K | 1.03 M | 367 K | 1.03 M | 1.14 M | 1.54 M | 1.19 M | 1.54 M | 1.54 M | 1.79 M | 1.39 M | 1.79 M | 1.67 M | 1.98 M | 1.63 M | 1.98 M | 1.18 M | 1.7 M | 2 M | 1.7 M | 2 M | 1.7 M | 2 M |
Operating Income |
-557 K | - | -1.56 M | -1.73 M | -1.04 M | - | -2.02 M | -1.44 M | -1.21 M | - | -1.1 M | -3.14 M | -1.66 M | - | -1.08 M | -5.19 M | -1.21 M | - | -330 K | -262 K | -906 K | - | -1.94 M | -30.5 M | -3.26 M | - | -2.12 M | -3.57 M | -2.35 M | -3.57 M | -2.74 M | -1.97 M | -3.91 M | -1.97 M | -4.84 M | -4.35 M | -3.29 M | -4.35 M | -1.86 M | -1.6 M | -2.3 M | -1.6 M | -2.3 M | -1.6 M | -2.3 M | -558 K | 992 K | - | - | - | - | - | - |
Interest Expense |
1.45 M | - | 2.12 M | 668 K | 3.9 M | - | 1.39 M | 1.36 M | 823 K | - | 1.53 M | 1.52 M | 1.52 M | - | 1.53 M | 1.31 M | 3.53 M | - | 1.19 M | 1.21 M | 1.13 M | - | 835 K | 383 K | 361 K | - | 19 K | 2 K | 198 K | 2 K | -8.13 M | 10.5 M | 10.5 M | 14 K | 7 K | - | 25 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
-223 K | - | -741 K | -1.2 M | -778 K | - | -1.35 M | -1.03 M | -1.06 M | - | -628 K | -2.82 M | -1.5 M | - | -514 K | -4.8 M | -1.01 M | - | -128 K | -72 K | -694 K | - | -1.76 M | -30.3 M | -3.1 M | - | -1.46 M | -3.1 M | -2.19 M | -3.57 M | -1.86 M | -1.31 M | -3.55 M | -1.97 M | -3.82 M | -3.69 M | -2.96 M | -4.24 M | -1.27 M | -1.28 M | -2.14 M | -1.6 M | -1.9 M | -1.34 M | -2.16 M | -558 K | 1.38 M | 202 K | 99 K | - | 99 K | 202 K | 99 K |
Operating Expenses |
1.76 M | - | 1.95 M | 2.2 M | 2.15 M | - | 2.45 M | 2.38 M | 2.15 M | - | 2.22 M | 4.12 M | 2.37 M | - | 2.59 M | 2.56 M | 2.7 M | - | 2.22 M | 2.21 M | 2.16 M | - | 2.59 M | 30.9 M | 3.61 M | - | 3.49 M | 5.12 M | 3.28 M | 5.12 M | 3.15 M | 3 M | 4.28 M | 3 M | 5.98 M | 5.89 M | 4.47 M | 5.89 M | 3.4 M | 3.39 M | 3.69 M | 3.39 M | 2.8 M | 2.53 M | 634 K | 2.53 M | 2.94 M | 3.03 M | 3.24 M | 3.03 M | 3.24 M | 3.03 M | 3.24 M |
General and Administrative Expenses |
1.55 M | - | 1.69 M | 1.82 M | 1.84 M | - | 1.98 M | 1.99 M | 1.69 M | - | 1.68 M | 3.5 M | 1.99 M | - | 1.3 M | 1.54 M | 1.65 M | - | 1.14 M | 1.22 M | 1.26 M | - | 1.62 M | 2.4 M | 2.24 M | - | 2.59 M | 4.14 M | 1.7 M | 4.14 M | 1.9 M | 1.82 M | 2.55 M | 1.82 M | 3.48 M | 3.63 M | 2.19 M | 3.63 M | 1.94 M | 1.88 M | 2.14 M | 1.88 M | 1.56 M | 1.88 M | 2.14 M | 1.08 M | 1.14 M | - | 1.27 M | - | - | - | - |
Quarterly performance
Select metrics to display
All numbers in USD currency
The income statement is one of the three key financial reports of a company ThermoGenesis Holdings (alongside the balance sheet and the cash flow statement). It shows how the company makes money and what its expenses are:
- How much revenue the company earned
- How much it spent on production, personnel, marketing, taxes, etc.
- What profit remained in the end
Analyzing the income statement helps an investor understand whether the business generates stable and growing profits, how effectively the company controls its expenses, and whether it is capable of generating income in the future. Additionally, this analysis shows how the company copes with crises and economic cycles, and allows assessing the potential for stock price growth and dividend payments.
Features- The income statement may include both recurring and one-time items (for example, profit from the sale of assets). It is necessary to separate core metrics from one-off events for accurate analysis.
- Companies often publish interim reports (e.g., quarterly), which allows for more timely tracking of trends.
- A combined analysis of the income statement with the balance sheet and cash flow statement provides a comprehensive view of the company’s financial health.
Israel
USA
France
Curacao
Costa-rica
Canada
Britain
